These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 36992399)

  • 21. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H; Choi J; Won KH
    BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
    Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
    J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application.
    Sun B; Chen H; Gao X
    J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
    Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
    Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-Free Genome Editing via Ribonucleoprotein (RNP) Delivery of CRISPR/Cas in Lettuce.
    Park J; Choi S; Park S; Yoon J; Park AY; Choe S
    Methods Mol Biol; 2019; 1917():337-354. PubMed ID: 30610648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.
    Molaei Z; Jabbarpour Z; Omidkhoda A; Ahmadbeigi N
    Stem Cell Res Ther; 2024 Jul; 15(1):233. PubMed ID: 39075609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
    Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
    Campbell LA; Richie CT; Maggirwar NS; Harvey BK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
    Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
    J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient in vivo neuronal genome editing in the mouse brain using nanocapsules containing CRISPR-Cas9 ribonucleoproteins.
    Metzger JM; Wang Y; Neuman SS; Snow KJ; Murray SA; Lutz CM; Bondarenko V; Felton J; Gimse K; Xie R; Li D; Zhao Y; Flowers MT; Simmons HA; Roy S; Saha K; Levine JE; Emborg ME; Gong S
    Biomaterials; 2023 Feb; 293():121959. PubMed ID: 36527789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing.
    Whitley JA; Cai H
    J Extracell Vesicles; 2023 Sep; 12(9):e12343. PubMed ID: 37723839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
    Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
    J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
    Im SH; Jang M; Park JH; Chung HJ
    J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNP-Based Control Systems for Genetic Circuits in Synthetic Biology Beyond CRISPR.
    Simmons TR; Ellington AD; Contreras LM
    Methods Mol Biol; 2022; 2518():1-31. PubMed ID: 35666436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-viral delivery of the CRISPR/Cas system: DNA
    Lin Y; Wagner E; Lächelt U
    Biomater Sci; 2022 Mar; 10(5):1166-1192. PubMed ID: 35103261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.